Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Argus Health
US Army
Julphar
Teva
Healthtrust
Fuji
Farmers Insurance

Generated: May 26, 2018

DrugPatentWatch Database Preview

Procyclidine hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for procyclidine hydrochloride and what is the scope of procyclidine hydrochloride patent protection?

Procyclidine hydrochloride
is the generic ingredient in one branded drug marketed by Monarch Pharms and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for procyclidine hydrochloride.
Summary for procyclidine hydrochloride
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Bulk Api Vendors: 31
Patent Applications: 281
DailyMed Link:procyclidine hydrochloride at DailyMed
Medical Subject Heading (MeSH) Categories for procyclidine hydrochloride
Synonyms for procyclidine hydrochloride
( inverted exclamation markA)-Procyclidine hydrochloride
(-)-1-(3-Cyclohexyl-3-hydroxy-3-phenylpropyl)-1-methylpyrrolidinium iodide
(-)-Procyclidine methyl iodide
(-)-Tricyclamol iodide
1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride
1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol hydrochloride
1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol;hydrochloride
1-cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol hydrochloride
1-Pyrrolidinepropanol, alpha-cyclohexyl-alpha-phenyl-, hydrochloride
1-Pyrrolidinepropanol, alpha-cyclohexyl-alpha-phenyl-, monohydrochloride
1508-76-5
30953-84-5
508P765
AC1L4JJJ
AKOS030575627
alpha-Cyclohexyl-alpha-phenyl-1-pyrrolidinepropanol
alpha-Cyclohexyl-alpha-phenyl-1-pyrrolidinepropanol hydrochloride
alpha-Cyclohexyl-alpha-phenyl-1-pyrrolidinepropanolhydrochloride
AN-19714
API0025896
C19H29NO.HCl
CAS-1508-76-5
CCG-39236
CHEBI:8449
CHEMBL1761
CPD000058821
CS-5893
CTK4G6182
D00782
DSSTox_CID_25357
DSSTox_GSID_45357
DSSTox_RID_80823
DTXSID8045357
EINECS 216-141-8
FT-0674043
HMS1570J09
HMS1920L10
HY-B1487
J-008753
Kemadrin (TN)
LS-138143
LS-138318
MLS000028556
MLS001076129
MLS002222170
NC00585
NCGC00016585-01
NCGC00018186-07
NCGC00094769-01
NCGC00094769-02
NCGC00094769-03
NCGC00094769-04
NSC-757293
NSC757293
Opera_ID_270
Pharmakon1600-01500507
Prestwick_125
Procyclidine (hydrochloride)
Procyclidine HCl
Procyclidine hydrochloride (USP)
Procyclidine hydrochloride [USAN]
Procyclidine hydrochloride [USP]
Procyclidine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Pyrrolidinium, 1-(3-cyclohexyl-3-hydroxy-3-phenylpropyl)-1-methyl-, iodide, (-)-
REGID_for_CID_207841
SAM002564231
SCHEMBL121684
SMR000058821
SPECTRUM1500507
Tox21_110508
Tox21_110508_1
Tricyclamol hydrochloride
Y0487

US Patents and Regulatory Information for procyclidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Monarch Pharms KEMADRIN procyclidine hydrochloride TABLET;ORAL 009818-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Monarch Pharms KEMADRIN procyclidine hydrochloride TABLET;ORAL 009818-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Farmers Insurance
Cipla
UBS
Cantor Fitzgerald
Harvard Business School
Teva
Fish and Richardson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.